about
Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanismsDNA topoisomerase II is essential for preimplantation mouse developmentT1 measurements in cell cultures: a new tool for characterizing contrast agents at 1.5T.Chemical approaches to control gene expression.Efficient silencing of gene expression by an ASON-bulge-DNAzyme complex.Oligonucleotide directed misfolding of RNA inhibits Candida albicans group I intron splicingDeveloping G-quartet oligonucleotides as novel anti-HIV agents: focus on anti-HIV drug design.Protein kinase C inhibitors as novel anticancer drugs.Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotidesEnhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia.Vascular complications and gene therapy.Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.Oligonucleotides and polyribonucleotides: a review of antiviral activity.Clinical trials of a new class of therapeutic agents: antisense oligonucleotides.IAP-targeted therapies for cancer.Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549.Assessment of the cellular response to the induced expression of defensin sense and antisense cDNA in acute promyelocytic leukemia cell lines.Inhibition of Escherichia coli RNase P by oligonucleotide directed misfolding of RNAOligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.Inhibition of sodium butyrate-induced apoptosis in recombinant Chinese hamster ovary cells by constitutively expressing antisense RNA of caspase-3.Complex formation of divalent metal ions with uridine 5'-O-thiomonophosphate or methyl thiophosphate: comparison of complex stabilities with those of the parent phosphate ligands.Emerging therapies for hepatitis C virus infection.Brief communication: stability and catalytic activity of novel circular DNAzymes.Selection of effective antisense oligodeoxynucleotides with a green fluorescent protein-based assay
P2860
Q28292633-21DEDA60-D094-4EEA-97AA-55273DA0F61BQ28589046-FDBED356-766D-42BB-BCBD-9F2124A53FF1Q30667093-921E5307-0024-4515-80CF-D45BDC7A8E11Q30971784-27D7F32F-BCA2-48F2-A862-5980ADECBBDBQ33872170-98B269CF-613B-4675-AEEE-08D0F9D117A5Q34036939-74E457FE-74E7-463A-98E1-D9CECC47A85AQ34075007-F1BCC217-F8B8-4C9E-AFF1-DFEC2AD5E786Q34481881-60F186AE-6EA9-4FC4-AD06-7AC72F6288C9Q34879217-A56868D7-4E1A-4256-BFCD-C955FACE879EQ34904790-F86F6FB4-5652-4B50-8CC0-B3687A231685Q34921907-71B0A51E-CA6F-48BA-8D65-401D6153A04BQ35022511-796C6A1B-57FB-4996-A455-F08F782F6903Q35116151-69DBDDF0-B3CF-47D7-89AE-C3763BE544E6Q35901019-8AE4232E-0CA1-4787-830D-9D483054CEB0Q36124734-D59F3E5E-A2F0-41BC-AF46-EBBABCE01FA9Q36179648-9C7D0287-CF77-4B60-9428-79ECD1485FA8Q37302745-D51E23F1-05A1-43D9-8D6E-B957054B8591Q38296989-5526368A-174F-4CC7-9600-D230EABF2465Q39185508-544FFFA4-ADB0-426B-870F-486E7B7136D0Q40397695-B7592A2A-F599-4FD6-A1BC-335256B2F16FQ41815423-C6070B76-FA64-4BD2-ACB2-26C9FC477EBEQ42207445-92F950DA-09BF-4DF6-9DA5-F13C1ED640B7Q43643744-E500210E-BE2C-4ADB-9291-478A6CD817A5Q43900075-6D553CE5-7C85-45A4-B349-40C30DC9633CQ44507348-1D4E72B8-8DF2-4BEF-B352-E05F28F94EF4Q45440609-0315E180-3E7B-4290-966F-ADCDD747715DQ52931277-FEB25C76-CCFF-40F7-A3C8-1E81071DFDA2Q58223938-AF0C3C49-1308-4F11-A967-DF02E5CB3B4A
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Antisense oligonucleotides as therapeutic agents.
@ast
Antisense oligonucleotides as therapeutic agents.
@en
type
label
Antisense oligonucleotides as therapeutic agents.
@ast
Antisense oligonucleotides as therapeutic agents.
@en
prefLabel
Antisense oligonucleotides as therapeutic agents.
@ast
Antisense oligonucleotides as therapeutic agents.
@en
P2860
P1476
Antisense oligonucleotides as therapeutic agents.
@en
P2093
Galderisi U
P2860
P304
P356
10.1002/(SICI)1097-4652(199911)181:2<251::AID-JCP7>3.0.CO;2-D
P577
1999-11-01T00:00:00Z